Radiopaque Substance for Additive Manufacturing with AI, IoT, and Blockchain Integration

Publication ID: 24-11857649_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Radiopaque Substance for Additive Manufacturing with AI, IoT, and Blockchain Integration,” Published Technical Disclosure No. 24-11857649_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857649_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,649.

Summary of the Inventive Concept

The present invention relates to a curable radiopaque substance and its integration with AI-driven optimization, IoT-enabled sensors, and blockchain-based tracking to create a novel system for additive manufacturing, monitoring, and customization of radiopaque products.

Background and Problem Solved

The original patent disclosed a curable radiopaque substance suitable for producing materials with high X-ray absorption. However, the original patent did not provide a comprehensive system for additive manufacturing, tracking, and customization of radiopaque products. The present inventive concept addresses this limitation by combining the curable radiopaque substance with AI, IoT, and blockchain technologies.

Detailed Description of the Inventive Concept

The inventive concept comprises a curable radiopaque substance, a digital data model, and an AI-driven optimization module for generating optimal printing parameters. The system further integrates an IoT-enabled sensor for detecting changes in the material's properties and a blockchain-based tracking system for monitoring the material's properties and usage history. The inventive concept enables the production of customized radiopaque products with enhanced performance, reliability, and traceability.

Novelty and Inventive Step

The novel combination of the curable radiopaque substance with AI-driven optimization, IoT-enabled sensors, and blockchain-based tracking provides an inventive step beyond the original patent. The integration of these technologies enables a new system for additive manufacturing, monitoring, and customization of radiopaque products, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different AI algorithms, IoT sensors, or blockchain platforms. Variations may also include the integration of additional technologies, such as machine learning or computer vision, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the fields of additive manufacturing, healthcare, and industrial materials. The system's ability to produce customized radiopaque products with enhanced performance and traceability makes it an attractive solution for industries requiring high-quality materials with specific properties.

CPC Classifications

SectionClassGroup
A A61 A61K6/70
A A61 A61K6/847
A A61 A61K6/887
C C08 C08F220/12

Field of Art

Dental and medical materials science, specifically polymer chemistry and additive manufacturing of radiopaque substances, with expertise in material composition, polymerization techniques, and advanced manufacturing technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in materials science or chemical engineering, familiar with polymer chemistry, radiopaque material formulation, 3D printing technologies, and emerging digital manufacturing techniques

Obviousness Rationale

A person having ordinary skill would recognize that integrating digital technologies like AI, IoT, and blockchain with existing radiopaque substance formulations represents a predictable application of known technological enhancement strategies. The core radiopaque substance composition remains fundamentally consistent with the source patent, while the proposed digital systems provide incremental process improvements that would be obvious to implement. The technical variations represent standard engineering approaches to extending material manufacturing capabilities through digital monitoring and optimization techniques.

Obvious Combinations & Variations

Source Patent Element
Curable substance with polymerization monomers and radiopaque compounds
PTD Variation
Adding AI-driven optimization module for generating printing parameters
Obviousness Reasoning
Predictable application of machine learning to optimize manufacturing parameters for known material compositions, representing a routine engineering enhancement
Source Patent Element
Polymerizable monomers including acrylic and methacrylic derivatives
PTD Variation
Integrating IoT-enabled sensors for monitoring material properties during manufacturing
Obviousness Reasoning
Known technique of implementing real-time monitoring systems for material processing, providing incremental performance improvement through standard sensor technologies
Source Patent Element
Curable radiopaque substance for medical/dental applications
PTD Variation
Blockchain-based tracking system for monitoring material properties and usage history
Obviousness Reasoning
Obvious extension of existing traceability requirements in medical materials, applying emerging digital tracking technologies to established material science practices
Source Patent Element
Polymerization process for creating radiopaque materials
PTD Variation
Computer-aided design integration for customized product generation
Obviousness Reasoning
Predictable application of digital design tools to customize manufacturing processes, representing a standard approach in advanced manufacturing technologies
Source Patent Element
Compounds including strontium, zirconium, lead, barium, bismuth derivatives
PTD Variation
Machine learning algorithms for predicting material performance characteristics
Obviousness Reasoning
Routine implementation of data analysis techniques to enhance understanding of material properties, representing an obvious technological progression
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art of radiopaque material science, when viewed in light of US Patent 11857649. The incremental technological enhancements representing digital integration and process optimization constitute predictable variations that do not rise to the level of non-obvious innovation, thereby establishing this disclosure as anticipatory prior art against potential future patent claims in this technological domain.

Original Patent Information

Patent NumberUS 11,857,649
TitleCurable radiopaque substance
Assignee(s)Merz Dental GmbH